Mountain Hill Investment Partners’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.32K Hold
10
﹤0.01% 152
2026
Q1
$1.22K Sell
10
-547
-98% -$63.2K ﹤0.01% 150
2025
Q4
$58.6K Hold
557
0.04% 54
2025
Q3
$46.7K Buy
557
+10
+2% +$824 0.04% 61
2025
Q2
$43.3K Buy
+547
New +$43.5K 0.04% 68

Other funds holding MRK

Mountain Hill Investment Partners's MRK Position: Q2 2026 in Review

Mountain Hill Investment Partners held its Merck (MRK) position steady in Q2 2026 at 10 shares worth $1.32K. The position accounts for ﹤0.01% of the portfolio, ranked #152.

Mountain Hill Investment Partners first reported a position in MRK in Q2 2025 and has held it in 5 quarters since. The position peaked at $58.6K in Q4 2025. 1,299 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Mountain Hill Investment Partners held 10 shares of Merck worth $1.32K as of Q2 2026.
  • Mountain Hill Investment Partners left its Merck share count unchanged in Q2 2026.
  • Merck made up ﹤0.01% of Mountain Hill Investment Partners's portfolio in Q2 2026, its #152 holding.
  • Mountain Hill Investment Partners first reported a position in Merck in Q2 2025 and has held it in 5 quarters since.
  • Mountain Hill Investment Partners's Merck position peaked at $58.6K in Q4 2025.
  • 1,299 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Mountain Hill Investment Partners's 13F filing for Q2 2026, filed 16 Jul 2026.